Key result
Chronic administration of IRL-1620 decreased systolic blood pressure in DOCA-salt hypertensive rats but not in normotensive animals.
Why the study?
Previous findings suggested endogenous endothelins bind to brain ETB to regulate tyrosine hydroxylase in the olfactory bulb, but the role of central ETB stimulation on blood pressure and olfactory bulb catecholaminergic regulation in DOCA-salt hypertensive rats remained to be evaluated.
Does central ETB stimulation with IRL-1620 reduce blood pressure and alter the catecholaminergic system in the olfactory bulb of DOCA-salt hypertensive rats?
Does central ETB stimulation with IRL-1620 reduce blood pressure and alter the catecholaminergic system in the olfactory bulb of DOCA-salt hypertensive rats?
Answers are grounded in this paper and cite their sources.
Central ETB receptor activation with IRL-1620 reduces systolic blood pressure in DOCA-salt hypertensive rats, suggesting a role for brain endothelins in blood pressure regulation in this model.
Background: We previously reported that endothelins (ETs) regulate tyrosine hydroxylase (TH) activity and expression in the olfactory bulb (OB) of normotensive and hypertensive animals. Applying an ET receptor type A (ETA) antagonist to the brain suggested that endogenous ETs bind to ET receptor type B (ETB) to elicit effects. Objective: The aim of the present work was to evaluate the role of central ETB stimulation on the regulation of blood pressure (BP) and the catecholaminergic system in the OB of deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Methods: DOCA-salt hypertensive rats were infused for 7 days with cerebrospinal fluid or IRL-1620 (ETB receptor agonist) through a cannula placed in the lateral brain ventricle. Systolic BP (SBP) and heart rate were recorded by plethysmography. The expression of TH and its phosphorylated forms in the OB were determined by immunoblotting, TH activity by a radioenzymatic assay, and TH mRNA by quantitative real-time polymerase chain reaction. Results: Chronic administration of IRL-1620 decreased SBP in hypertensive rats but not in normotensive animals. Furthermore, the blockade of ETB receptors also decreased TH-mRNA in DOCA-salt rats, but it did not modify TH activity or protein expression. Conclusion: These findings suggest that brain ETs through the activation of ETB receptors contribute to SBP regulation in DOCA-salt hypertension. However, the catecholaminergic system in the OB does not appear to be conclusively involved although mRNA TH was reduced. Present and previous findings suggest that in this salt-sensitive animal model of hypertension, the OB contributes to chronic BP elevation.
No takes yet. Share an insight, caveat, or question.
Cassinotti et al. (2023) studied DOCA-salt hypertension. IRL-1620 (ETB receptor agonist) vs. Cerebrospinal fluid was evaluated on Systolic blood pressure (SBP). Chronic administration of IRL-1620 decreased systolic blood pressure in DOCA-salt hypertensive rats but not in normotensive animals.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: